Dassault Systemes

Dr. Jill Biden, National Minority Quality Forum, Global Sponsors and CROs Discuss the Future of Healthcare and Clinical Research at Medidata NEXT NYC 2018

Press Release
October 23, 2018

Over 1,000 industry leaders to discuss best practices and the hottest topics in the digital transformation of life sciences

News Summary

  • The two-day program features keynotes from global sponsors and CROs and over 50 breakout sessions

  • Over 1,000 attendees to share best practices and connect with fellow life science industry leaders

  • Conference breakouts offer attendees interactive, hands-on learning opportunities to design, conduct, manage, and monitor the next generation of clinical research studies

NEW YORK - Oct. 23, 2018 - Medidata NEXT NYC, the premier conference on the digital transformation of life sciences, will feature keynotes from global sponsors and CROs, and Medidata (NASDAQ: MDSO). The customer conference runs from October 24-25 at Spring Studios in New York City.

Medidata NEXT NYC is the centerpiece of the global conference series Medidata NEXT, an industry nexus where science meets technology meets the future. The event’s keynotes include visionaries who are at the leading edge of healthcare industry innovation:

  • Dr. Jill Biden, educator and former Second Lady of the United States (2009-2017)

  • Jeff Allen, Ph.D., president and CEO of Friends of Cancer Research

  • Gary A. Puckrein, Ph.D., president and CEO of the National Minority Quality Forum

Thought-provoking breakout sessions will highlight cutting-edge innovation within each phase of the clinical development lifecycle, including study planning and execution, trial management, data analytics, patient engagement, and risk-based monitoring. Medidata customers and partners will lead over 80% of these sessions, featuring senior executives and experts from global sponsors and CROs.

To inspire innovation around greater diversity in clinical trials, Medidata NEXT NYC will also host a two-day hackathon: Closing the Diversity Gap in Clinical Trials. The hackathon will inspire innovators to create novel mobile applications with the Medidata AppConnect software kit to increase diversity and inclusion in clinical trials.

“Hearing stories of innovation and success from more than 1,000 life science leaders is a great source of inspiration and pride,” said Glen de Vries, president and co-founder, Medidata. “NEXT NYC is a reflection of our company’s true partnership with sponsors and CROs who are improving patient lives around the world.”

About Medidata NEXT:

The largest annual event series of its kind, Medidata NEXT attracts over 3,000 leaders in drug and device development, clinical operations, data management, biostatistics, and digital medicine innovation industries for networking and learning across seven gatherings in Basel, Frankfurt, London, New York, Seoul, Shanghai and Tokyo.

About Medidata

Medidata is leading the digital transformation of life sciences, with the world's most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata serves more than 1,000 customers and partners worldwide and empowers more than 100,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.mdsol.com